共 50 条
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
被引:0
|作者:
R. Mercieca-Bebber
E. H. Barnes
K. Wilson
Z. Samoon
E. Walpole
T. Mai
S. Ackland
M. Burge
G. Dickie
D. Watson
J. Leung
T. Wang
R. Bohmer
D. Cameron
J. Simes
V. Gebski
M. Smithers
J. Thomas
J. Zalcberg
A. P. Barbour
机构:
[1] University of Sydney,National Health and Medical Research Council (NHMRC) Clinical Trials Centre, Faculty of Medicine and Health
[2] Princess Alexandra Hospital,Division of Cancer Services
[3] University of Queensland,School of Clinical Medicine
[4] The University of Queensland,Faculty of Medicine
[5] University of Newcastle,School of Medicine and Public Health
[6] Royal Brisbane and Women’s Hospital,Cancer Care Services
[7] Flinders University,Discipline of Surgery, College of Medicine and Public Health
[8] GenesisCare St Andrew’s Hospital,Crown Princess Mary Cancer Center, Westmead hospital; Faculty of Medicine and Health
[9] University of Sydney,School of Public Health and Preventive Medicine
[10] Hobart Private Hospital,undefined
[11] Townsville University Hospital,undefined
[12] Divisions of Surgery and Cancer Services,undefined
[13] Princess Alexandra Hospital,undefined
[14] GIAST Clinic Mater Medical Centre South Brisbane,undefined
[15] Monash University,undefined
来源:
BMC Cancer
|
/
22卷
关键词:
Oesophageal adenocarcinoma;
Gastro-oesophageal adenocarcinoma;
Neoadjuvant therapy;
Quality of life;
Patient-reported outcomes;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
引用
收藏
相关论文